Miltown-200

Miltown-200 Brand names, Miltown-200 Analogs

Miltown-200 Brand Names Mixture

No information avaliable

Miltown-200 Chemical_Formula

C₂₀H₂₃NS

Miltown-200 RX_link

No information avaliable

Miltown-200 fda sheet

Miltown-200 msds (material safety sheet)

Miltown-200 Synthesis Reference

No information avaliable

Miltown-200 Molecular Weight

309.469 g/mol

Miltown-200 Melting Point

< 25 ^oC

Miltown-200 H₂O Solubility

Soluble as HCl salt

Miltown-200 State

Liquid

Miltown-200 LogP

5.7

Miltown-200 Dosage Forms

Tablets (oral, 1 mg)

Miltown-200 Indication

Used for the symptomatic treatment of parkinsonism.

Miltown-200 Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Miltown-200 Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Miltown-200 side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Miltown-200 Patient Information

Miltown-200 Organisms Affected

Humans and other mammals